Delivery Order SPE2DB22D2211-SPE2DB24FMAY3
Award Date 10/30/23
Potential Completion Date 10/31/23
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,361.42 delivery order contract is for the supply of Buprenorphine-Nalox 8-2mg film, a medication used to treat opioid dependence. The contract has a completion date of May 18, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.75 firm-fixed-price delivery order is for the supply of buprenorphine 0.3 mg/ml vials, a medication used for the treatment of opioid dependence. The award was made under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of buprenorphine-naloxone 8-2 milligram film, a specialty pharmaceutical product, with a ceiling value of $1,598.45 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a major supplier of pharmaceuticals and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for buprenorphine-naloxone 8-2mg film in 30-count packages, with a ceiling value of $1,064.64 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Buprenorphine 0.3 mg/mL vials. The $1,994.01 firm fixed-price delivery order has a completion date of March 22, 2023. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award, valued at $2,212.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557093564 - Buprenorphine 0.3 mg/ml vials. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical worth up to $999,999,999. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for the delivery of BUPRENORPHINE 0.3 MG/ML VIALML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,389.00 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Buprenorphine 0.3 mg/mL vials. The delivery order, valued at $3,472.50, has a firm-fixed-price contract type and a period of performance through September 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this order as part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
- The Defense Logistics Agency awarded a $376.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 units of 8-2mg Buprenorphine-Naloxone film. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is July 10-11, 2023. As the DLA supports military treatment and procurement programs, this contract for opioid addiction treatment medication will likely supply an on-base pharmacy. Amerisourcebergen, a subsidiary of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...